ArticleSurgical endoscopy2026
Optimal timing of endoscopic submucosal dissection for gastric epithelial neoplasms: impact of preoperative waiting time on clinical outcomes.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Impact of time from diagnosis to endoscopic resection on clinical outcomes in early gastric cancer.Annals of medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEndoscopic submucosal dissection (ESD) is considered the standard treatment for gastric epithelial neoplasms (GEN). However, the waiting time between the diagnosis of GEN and undergoing ESD varies among patients, and its effect on clinical outcomes remains to be elucidated. This study aimed to assess the impact of waiting time on clinical outcomes in patients undergoing ESD for GEN.
methodsThis retrospective study included 797 patients with 994 lesions who underwent ESD for GEN between April 2013 and March 2018. Waiting time was defined as the period between endoscopic diagnosis and ESD. Patients were divided into two groups based on waiting time: < 90 days (short group) and ≥ 90 days (long group). The primary outcome was disease-specific survival, and secondary outcomes included overall survival, the cumulative incidence of metachronous GEN, and curative resection rates.
resultsProlonged waiting time was associated with ASA PS III and a preoperative histological diagnosis of non-cancer. Short-term outcomes were unaffected by waiting time. Specially, the odds of non-curative resection did not significantly change for 30-day increments in waiting time (OR 1.09; 95%CI 0.94-1.25; p = 0.25). Hazard function analysis suggested a visual upward trend in the risk of non-curative resection after 180 days. Long-term outcomes were unaffected by waiting time.
conclusionsIn conclusion, waiting times up to one year were not associated with clinical outcomes. A potential risk increase after 180 days was suggested visually but remained statistically inconclusive, serving only as an exploratory reference point.
Indexed as
Identifiers
42301471What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.